BlackRock Fund Advisors’s iRadimed IRMD Stock Holding History

BlackRock Fund Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.42M	Buy	128,299 +16,734	+15%	+$180K	﹤0.01%	3201
2016 Q3	$1.9M	Buy	111,565 +6,282	+6%	+$116K	﹤0.01%	3172
2016 Q2	$2.29M	Buy	105,283 +28,638	+37%	+$515K	﹤0.01%	3159
2016 Q1	$1.47M	Buy	76,645 +546	+0.7%	+$10.4K	﹤0.01%	3138
2015 Q4	$2.13M	Buy	76,099 +9,870	+15%	+$279K	﹤0.01%	3139
2015 Q3	$1.61M	Sell	66,229 -423	-0.6%	-$10.1K	﹤0.01%	3156
2015 Q2	$1.55M	Buy	+66,652	New	+$1.22M	﹤0.01%	3185

Other funds holding IRMD

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ACM

Ativo Capital Management Chicago, Illinois $115M AUM 19.02% 1-Year Est. Return

BlackRock Fund Advisors's IRMD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its iRadimed (IRMD) stake by 15% in Q4 2016, buying an estimated $180K and bringing the position to 128,299 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

BlackRock Fund Advisors first reported a position in IRMD in Q2 2015 and has held it in 7 quarters since. The position peaked at $2.29M in Q2 2016. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

BlackRock Fund Advisors held 128,299 shares of iRadimed worth $1.42M as of Q4 2016.
BlackRock Fund Advisors bought 16,734 iRadimed shares in Q4 2016, an estimated $180K.
iRadimed made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3201 holding.
BlackRock Fund Advisors first reported a position in iRadimed in Q2 2015 and has held it in 7 quarters since.
BlackRock Fund Advisors's iRadimed position peaked at $2.29M in Q2 2016.
58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.